Basophil activation by secreted substances from N brasiliensis. (A,C) β-hexosaminidase release from the basophil-like murine cell line IC-2 (A) or bone marrow–derived basophils (C) before (■) or after sensitization with serum from N brasiliensis–infected wild-type mice (□) or IL-4/IL-13–deficient mice (▩). Cultures were stimulated with antigen from total larval extract (NEXL3) or secreted larval antigen (NESL3), which were generated as described in Document S1. Control indicates samples that were sensitized but not exposed to antigen; TNP, samples which were sensitized with anti-TNP IgE mAb (□) or not (■) and stimulated with TNP-BSA as positive control. *P < .005. (B) β-hexosaminidase release from IC-2 cells that were either sensitized with serum from N brasiliensis–infected wild-type mice (□) or with anti-TNP IgE (▩) and stimulated with NESL3. ■ indicates untreated controls. (D,E) IL-4 or IL-13 release from bone marrow–derived basophils after sensitization and stimulation as described in panel C. *P < .005. Bars show the mean plus SD from triplicate samples. n.d. indicates not detectable. The results are representative of 3 independent experiments. (F) Semiquantiative RT-PCR analysis of IL-4, IL-5, and IL-13 expression in bone marrow–derived basophils that were left untreated (control) or stimulated for 6 hours with NESL3 (stimulated) after cells had been sensitized with serum from N brasiliensis–infected mice.